Dr. Yun Kao
Board Certified Dermatologist and Dermatopathologist
Dr. Yun Kao is a board-certified dermatologist and fellowship-trained dermatopathologist. She received her undergraduate degree from Massachusetts Institute of Technology and earned her medical degree from Harvard Medical School. She completed residency at the Harvard Combined Dermatology Residency Training Program, where she served as chief resident in her final year of training. She subsequently completed a dermatopathology fellowship at Beth Israel Deaconess Medical Center. She specializes in medical dermatology and dermatopathology with personal interests in acne, skin cancer detection and treatment, and interpretation of skin biopsy results in managing various rashes and growing lesions. She is excited to be practicing both clinical dermatology and dermatopathology at Tareen Dermatology and providing the best care possible to her patients. When she is not in clinic or at the microscope, Dr. Kao enjoys reading, hiking, and spending time with her family.
Locations
Education
BS Brain and Cognitive Sciences Concentration in Education – Massachusetts Institute of Technology 08/08-06/12
MD Medicine Harvard Medical School – 08/12-06/16
Postdoctoral Training
07/16-06/17 Intern Internal Medicine Brigham and Women’s Hospital
07/17-06/20 Resident, Dermatology – Harvard Combined Dermatology Residency Training Program
01/19-06/20 Chief Resident, Dermatology – Harvard Combined Dermatology Residency Training Program
07/21-06/22 Fellow, Dermatopathology – Beth Israel Deaconess Medical Center
Honors and Awards
2012 Hans-lukas Teuber award Massachusetts Institute of Technology – Academics
2012 Golden Beaver Award Massachusetts Institute of Technology – Impact on Campus Life
Medical Reviewer
- Hartman R, Xue Y, Markossian T, Joyce C, Mostaghimi A. Modeling the value of risk stratified skin cancer screening by dermatologists in the U.S. population. J Invest Dermatol 2018;138(5):S43. Doi: 10.1016/j.jid.2018.03.259.
- Hartman R, Xue Y, Karmouta R, Joyce C, Mostaghimi A. Development and validation of a simple model to predict the risk of keratinocyte carcinoma on screening total body skin examination. J Invest Dermatol 2019; 139(S46). Doi: 10.1016/j.jid.2019.03.346.
- Hartman RI, Xue Y, Singer S, Markossian TW, Joyce C, Mostaghimi A. Modeling the Value of Risk Stratified Skin Cancer Screening of Asymptomatic Patients by Dermatologists. Br J Dermatol. 2019. Doi: 10.1111/bjd.18816
- Rozenbaum D, Tung J, Xue Y, Hoang MP, Kroshinsky D. Skin biopsy in the diagnosis of intravascular lymphoma: a retrospective diagnostic accuracy study. J Am Acad Dermatol. 2019.
- Xue Y, Cohen JM, Tsiaras WG. Skin Autotomization and Regeneration--The African Spiny Mouse. JAMA Dermatology. 2015;151(11):1199.
- Xue Y, Cohen JM, Wright NA, Merola JF. Skin Signs of Rheumatoid Arthritis and its Therapy- Induced Cutaneous Side Effects. Am J Clin Dermatol. 2016 May;17(2):147–62.
- Xue Y, Burgin S. Primary Syphilis. In: Goldsmith LA, ed. VisualDx. Rochester, NY: VisualDx; 2017.
- Xue Y, Burgin S. Henoch-Schonlein Puprura. In: Goldsmith LA, ed. VisualDx. Rochester, NY: VisualDx; 2017.
- Xue Y, Burgin S. Ecthyma gangrenosum. In: Goldsmith LA, ed. VisualDx. Rochester, NY: VisualDx; 2017.
- Xue Y, Tan B, Burgin S. Scabies (pediatric). In: Goldsmith LA, ed. VisualDx. Rochester, NY: VisualDx; 2017.
- Xue Y, Rana J, Burgin S. Teaching & Learning Tips 10: Interspecialty teaching through inpatient dermatology consults. Int J Dermatol. 2018;57(8):985-988.
- Xue Y, Thakuria M. Merkel Cell Carcinoma Review. Hematol Oncol Clin North Am. 2018;33(1): 39-52.
